American Journal of Ophthalmology
Volume 137, Issue 1 , Pages 43-51 , January 2004

Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years

  • Maria Regina Chalita, MD

      Affiliations

    • Department of Ophthalmology Federal University of São Paulo, São Paulo, Brazil
    • Corresponding Author InformationInquiries to Maria Regina Chalita, MD, Cleveland Clinic Foundation, 9500 Euclid Ave, i31, Cleveland, OH 44195, USA; fax: (216) 445-8475
    • ,
  • Ana Luisa Höfling-Lima, MD, MBA

      Affiliations

    • Department of Ophthalmology Federal University of São Paulo, São Paulo, Brazil
    • ,
  • Augusto Paranhos Jr, MD

      Affiliations

    • Department of Ophthalmology Federal University of São Paulo, São Paulo, Brazil
    • ,
  • Paulo Schor, MD

      Affiliations

    • Department of Ophthalmology Federal University of São Paulo, São Paulo, Brazil
    • ,
  • Rubens Belfort Jr, MD, PhD, MBA

      Affiliations

    • Department of Ophthalmology Federal University of São Paulo, São Paulo, Brazil

,Accepted 29 July 2003.

References 

  1. Jones DB. Decision-making in the management of microbial keratitis. Ophthalmology. 1981;88:814–820
  2. Tuft SJ, Matherson M. In vitro antibiotic resistance in bacterial keratitis in London. Br J Ophthalmol. 2000;84:687–691
  3. Jensen HG, Felix C. In vitro antibiotic susceptibilities of ocular isolates in North and South America. Cornea. 1998;17:79–87
  4. Kunimoto DY, Sharma S, Garg P, Rao GN. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Ophthalmology. 1999;106:80–85
  5. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis. Ophthalmology. 1999;106:1313–1318
  6. Garg P, Sharma S, Rao GN. Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology. 1999;106:1319–1323
  7. Molinari H, Belfort R, Almada AT, Silva VLP. Laboratorial analysis of 247 patients with conjuctivitis, keratitis and endophthalmitis. [translation] Rev Bras Oftalmol. 1978;37:63–73
  8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test. The National Committee for Clinical Laboratory Standards. 1993;13(24):1–31
  9. Gritz DC, Hwang DG, Whitcher JP. New horizons in antibacterial therapy. Int Ophthalmol Clin. 1996;36:153–170
  10. Knauf HP, Silvany R, Southern PM, Risser RC, Wilson SE. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea. 1996;15:66–71
  11. Serdarevic ON. Role of the fluoroquinolones in ophthalmology. Int Ophthalmol Clin. 1993;33:163–178
  12. Carmichael TR, Wolpert M, Koornhof HJ. Corneal ulceration at an urban African hospital. Br J Ophthalmol. 1985;69:920–926
  13. Wahl JC, Katz HR, Abrams DA. Infectious keratitis in Baltimore. Ann Ophthalmol. 1991;23:234–237
  14. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 1980;90:38–47
  15. Upadhyay MP, Karmacharya PCD, Koirala S, Tuladhar NR, Bryan LE, Smolin G. Epidemiologic characteristics, predisposing factors and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol. 1991;111:92–99
  16. Everett SL, Kowalski RP, Karenchak LM, Landsittel D, Day R, Gordon YJ. An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunctivitis and blepharitis to newer and established topical antibiotics. Cornea. 1995;14:382–387
  17. Osato MS, Jensen HG, Trousdale MD, et al.  The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am J Ophthalmol. 1989;108:380–386
  18. Montan P. Endophthalmitis. Curr Opin Ophthalmol. 2001;12:75–81
  19. Ooishi M, Miyao M. Antibiotic sensitivity of recent clinical isolates from patients with ocular infections. Ophthalmologica. 1997;211(Suppl 1):15–24
  20. Liesegang TJ. Use of antimicrobials to prevent postoperative infection in patients with cataract. Curr Opin Ophthalmol. 2001;12:68–74
  21. Bovelacci A, Montini G, Ramacciotti PG. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Chemiotherapia. 1985;4:439–444
  22. Gwon A. Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Br J Ophthalmol. 1992;76:714–718
  23. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones. Ophthalmology. 2000;107:1497–1502
  24. von Rosenstiel N, Adam D. Quinolone antibacterials (an update of their pharmacology and therapeutic use). Drugs. 1994;47:872–901
  25. Chaudhry NA, Flynn HW, Murray TG, Tabandeh H, Mello MO, Miller D. Emerging ciprofloxacin-resistant Pseudomonas aeruginosa. Am J Ophthalmol. 1999;128:509–510

☆ Additional material for this article can be found on ajo.com. doi:10.1016/S0002-9394(03)00905-X

PII: S0002-9394(03)00905-X

doi: 10.1016/S0002-9394(03)00905-X

American Journal of Ophthalmology
Volume 137, Issue 1 , Pages 43-51 , January 2004

Article Tools